Stocks › MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC.
MRVI·Nasdaq·
United States·USD
$7.85
-0.67 (-7.86%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
MRVIS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of MRVI by members of U.S. Congress · 1 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Daniel S. GoldmanHouse · D · NY |
MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. · Stock |
Sale $1,001 - $15,000 |
May 19, 2023 | Apr 10, 2023 | Filing ↗ |
Whale Activity
Position changes in MRVI reported for 2026-06-30 by 9 tracked institutional filers
- Increased6
- New0
- Held0
- Decreased2
- Closed0
- No prior filing1
| Filer | Shares | Value | Change |
|---|---|---|---|
| GTCR LLC | 20.2M | $125.7M | — |
| BlackRock, Inc. | 10.0M | $62.2M | increased |
| MILLENNIUM MANAGEMENT LLC | 6.5M | $40.6M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.3M | $33.0M | decreased |
| RENAISSANCE TECHNOLOGIES LLC | 4.6M | $28.7M | increased |
| TWO SIGMA INVESTMENTS, LP | 2.3M | $14.1M | increased |
| CITADEL ADVISORS LLC | 2.1M | $13.2M | increased |
| Point72 Asset Management, L.P. | 2.0M | $12.5M | decreased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.1M | $6.7M | increased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by MRVI insiders, by quarter · Form 4
Recent Insider Transactions
207 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| ORESHACK KURTGeneral Counsel | Sale | −25.0K | $5.10 | $127K | Jun 10, 2026 | Form 4 ↗ |
| ORESHACK KURTGeneral Counsel | Sale | −25.0K | $5.06 | $126K | Jun 9, 2026 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Gift | +46.3K | $0.00 | $0 | Jun 9, 2026 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Gift | −46.3K | $0.00 | $0 | Jun 9, 2026 | Form 4 ↗ |
| Brust BerndChief Executive Officer · Director | Tax withholding | −351.0K | $5.02 | $1.8M | Jun 8, 2026 | Form 4 ↗ |
| GRAY SUSANNAHDirector | Grant / award | +46.3K | $0.00 | $0 | May 26, 2026 | Form 4 ↗ |
| MARKER LUKE JOSEPHDirector | Grant / award | +46.3K | $0.00 | $0 | May 26, 2026 | Form 4 ↗ |
| CUNNINGHAM SEAN LAURENCEDirector | Grant / award | +46.3K | $0.00 | $0 | May 26, 2026 | Form 4 ↗ |
| DeFord John ADirector | Grant / award | +46.3K | $0.00 | $0 | May 26, 2026 | Form 4 ↗ |
| MIHAS CONSTANTINE SDirector | Grant / award | +46.3K | $0.00 | $0 | May 26, 2026 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Grant / award Amended | +46.3K | $0.00 | $0 | May 26, 2026 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Grant / award | +46.3K | $4.38 | $203K | May 26, 2026 | Form 4 ↗ |
| ECKERT R ANDREWDirector | Grant / award | +46.3K | $0.00 | $0 | May 26, 2026 | Form 4 ↗ |
| ORESHACK KURTGeneral Counsel | Grant / award | +776 | $2.84 | $2K | May 15, 2026 | Form 4 ↗ |
| Dolan ChristineSee Remarks | Grant / award | +5,006 | $1.79 | $9K | May 15, 2026 | Form 4 ↗ |
| ORESHACK KURTGeneral Counsel | Tax withholding | −40.0K | $3.08 | $123K | Mar 16, 2026 | Form 4 ↗ |
| Dolan ChristineSee Remarks | Tax withholding | −28.7K | $3.08 | $88K | Mar 16, 2026 | Form 4 ↗ |
| ORESHACK KURTGeneral Counsel | Tax withholding | −31.9K | $3.69 | $118K | Jan 15, 2026 | Form 4 ↗ |
| Dolan ChristineSee Remarks | Tax withholding | −28.9K | $3.69 | $107K | Jan 15, 2026 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Purchase | +48.5K | $3.67 | $178K | Dec 8, 2025 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding MRVI · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3.7M | $23.1M | 0.00% | Jun 30, 2026 |
| First Eagle Small Cap Opportunity Fund First Eagle Funds | 3.2M | $21.3M | 0.73% | Jul 31, 2026 |
| iShares Russell 2000 ETF iShares Trust | 3.0M | $18.5M | 0.02% | Jun 30, 2026 |
| General American Investors Company, Inc. | 1.7M | $10.7M | 0.62% | Jun 30, 2026 |
| Nuveen Quant Small Cap Equity Fund TIAA-CREF Funds | 1.6M | $10.5M | 0.26% | Jul 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.5M | $9.1M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 1.3M | $8.3M | 0.09% | Jul 31, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 1.2M | $8.1M | 0.02% | Jul 31, 2026 |
| Meridian Contrarian Fund Meridian Fund Inc | 1.3M | $8.0M | 1.17% | Jun 30, 2026 |
| ROYCE MICRO-CAP TRUST, INC. | 1.1M | $7.1M | 0.78% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list MRVI's shares (CUSIP 56600D107), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Israel A. EnglanderSCHEDULE 13G · passive (13G) · 7.8M shares5.2%
Sep 29, 2026 · ↗ - Millennium Group Management LLCSCHEDULE 13G · passive (13G) · 7.8M shares5.2%
Sep 29, 2026 · ↗ - Millennium Management LLCSCHEDULE 13G · passive (13G) · 7.8M shares5.2%
Sep 29, 2026 · ↗ - Joshua WoolSCHEDULE 13G/A · passive (13G) · 45.0K shares0.0%
Aug 13, 2026 · ↗ - Matthew BarkoffSCHEDULE 13G/A · passive (13G) · 290.1K shares0.2%
Aug 13, 2026 · ↗ - Stuart FeldmanSCHEDULE 13G/A · passive (13G) · 3.7M shares2.5%
Aug 13, 2026 · ↗ - JD Squared Capital II LLCSCHEDULE 13G/A · passive (13G) · 3.0M shares2.0%
Aug 13, 2026 · ↗ - JD Squared Holdings II LLCSCHEDULE 13G/A · passive (13G) · 3.0M shares2.0%
Aug 13, 2026 · ↗ - Hudson View Capital LLCSCHEDULE 13G/A · passive (13G) · 674.1K shares0.5%
Aug 13, 2026 · ↗ - Hudson View Holdings LLCSCHEDULE 13G/A · passive (13G) · 674.1K shares0.5%
Aug 13, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming MARAVAI LIFESCIENCES HOLDINGS, INC. as client
No lobbying filings found naming MARAVAI LIFESCIENCES HOLDINGS, INC. as the client.
Government Contracts
Federal awards to MARAVAI LIFESCIENCES HOLDINGS, INC. · USAspending
No federal contract awards found for MARAVAI LIFESCIENCES HOLDINGS, INC..
U.S. Patents
Recent USPTO applications naming MARAVAI LIFESCIENCES HOLDINGS, INC.
No USPTO patent applications found for MARAVAI LIFESCIENCES HOLDINGS, INC..
Annual Financials
From MRVI's 10-K filings · XBRL
No annual XBRL figures on record for MRVI. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in MRVI's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
EDGAR ↗ - 8-K · Items 1.01, 1.02, 2.03, 7.01, 9.01Material agreement · Termination of agreement · Direct financial obligationJun 3, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteMay 29, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
EDGAR ↗
About MARAVAI LIFESCIENCES HOLDINGS, INC.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersSAN DIEGO, CA
IncorporatedDE
SEC CIK0001823239 ↗

